Information  X 
Enter a valid email address

Babcock Intnl Group (BAB)

  Print          Annual reports

Wednesday 09 September, 2020

Babcock Intnl Group

Publication of Base Prospectus

RNS Number : 3894Y
Babcock International Group PLC
09 September 2020

9 September 2020

Babcock International Group PLC (Babcock or the Group) 

Publication of Base Prospectus


The following base prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and is available for viewing:


The Prospectus dated 8 September 2020 relating to the Babcock International Group PLC £1,800,000,000 Euro Medium Term Note Programme (the "Programme").


S&P Global Ratings has confirmed its long-term public credit rating of BBB for the Programme.


Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.


To view the Prospectus, please paste the following URL into the address bar of your browser:  


A copy of the Prospectus will also be submitted to the National Storage Mechanism and will shortly be available for inspection at:





For further information please contact:


Babcock International Group PLC 

Simon McGough  Kate Hill

Director of Investor Relations  Group Director of Communications

Tel: +44 (0)7850 978 741  Tel: +44 (0)20 7355 5312



This announcement is not for distribution in the United States.

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.

In particular, neither this announcement nor the Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Prospectus have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, the securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons. The securities are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t